<DOC>
	<DOCNO>NCT02916875</DOCNO>
	<brief_summary>In 2015 Danish healthcare authority initiate major change follow-up ( FU ) program patient ovarian cancer . The new FU program argues effect routine monitoring , every patient 's FU individualize . These change cause major concern , especially regard omission routine examination aim detection recurrence , since clinical symptom relapse diffuse . Clearly , tool FU plan support patient feel safe FU vital importance . Patient-reported outcome measure ( PROM ) tool improve focus patient ' need , symptom preference . It also tool monitor quality life ( QoL ) , side effect . 300 patient ovarian cancer plan enrol primary treatment enter follow-up program . This multi-center study . All participant fill questionnaire baseline every 3 month two year , every 6 month third year . The questionnaire consist EORTC-QLQ-C30 , EORTC-OV28 , question symptoms relapse . At baseline questionnaire extend demographic issue . The patient also fill brief questionnaire ( CollaboRATE ) deal patient satisfaction level share decision making experience . All participant follow 3 year .</brief_summary>
	<brief_title>Individual Survivorship Program Ovarian Cancer Patients Based PROM 's Shared Decision Making</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Patients &gt; 18 year age . Histologically confirm epithelial ovarian , fallopian tube serous primary peritoneal cancer . Have complete first line treatment , complete remission . Manage read speak Danish . Can receive active anticancer treatment maintenance bevacizumab â€¢Have recurrent disease first line treatment .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Shared decision Making</keyword>
	<keyword>Follow-up</keyword>
</DOC>